Cover

Glaucoma Surgery

Editor(s): Bettin P. (Milan) 
Khaw P.T. (London) 
Table of Contents
Vol. 50, 2012
Section title: Paper
Bettin P, Khaw PT (eds): Glaucoma Surgery. Dev Ophthalmol. Basel, Karger, 2012, vol 50, pp 173–183
(DOI:10.1159/000334800)

When Should We Give Up Filtration Surgery: Indications, Techniques and Results of Cyclodestruction

Huang G. · Lin S.C.
aDepartment of Ophthalmology, University of California, San Francisco, Calif., USA; bState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, and cDepartment of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, China

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 33.00
Account: USD 23.00

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select


Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: 4/17/2012
Cover Date: 2012

Number of Print Pages: 11
Number of Figures: 2
Number of Tables: 1

ISBN: 978-3-8055-9937-5 (Print)
eISBN: 978-3-8055-9938-2 (Online)

Abstract

Purpose: Cyclodestructive procedures are traditionally used in cases of glaucoma that are refractory to medical and surgical therapy. The goal of this chapter is to describe indications, contraindications, techniques, and pitfalls of cyclodestructive procedures including transscleral cyclophotocoagulation (TCP) and endoscopic cyclophotocoagulation (ECP). Methods: A literature search for cyclophotocoagulation was performed. Relevant studies were included for evaluation and review. Results: It is encouraging that TCP seems relatively efficacious even for patients who have been refractory to other treatments, depending on the energy setting, follow-up period, and definition of success. Repeated TCP is often required. TCP was more often used in eyes with limited visual potential caused by severe forms of glaucoma than in eyes with good visual potential. Serious complications were significant vision loss, inflammation, hypotony, and phthisis. ECP came later into clinical use for the treatment of refractory glaucoma. ECP is able to specifically target the ciliary epithelium under direct viewing as compared to TCP, which is an indirect cyclodestructive procedure. In the literature, it has been demonstrated that ECP has overall good success with relatively low complication rates when used for adult forms of glaucoma. There appeared to be a tendency to perform ECP earlier when combined with cataract surgery for controlling intraocular pressure. Serious complications of ECP were hypotony-related disorders, macular edema, and choroidal and retinal detachment. Recent publications have shown that both TCP and ECP may be reasonable first-line surgeries or even first-line treatments. Conclusions: Both TCP and ECP are effective cyclodestructive procedures and alternatives for the treatment of glaucoma refractory to medical and surgical therapy, though potential for serious complications exists. Recent studies have indicated that TCP and ECP are used increasingly as the primary surgery for various kinds and stages of glaucoma.


  

Author Contacts

Shan C. Lin, Department of Ophthalmology, University of California, Box 0730, 10 Koret Street, San Francisco, CA 94133-0730 (USA), E-Mail LinS@vision.ucsf.edu

  

Article Information

Published online: April 17, 2012
Number of Print Pages : 11

  

Publication Details

Book Serie: Developments in Ophthalmology, Vol. 50, Year 2012

Editor(s): Bandello, F. (Milan)
ISSN: 0250-3751 (Print), eISSN: 1662-2790 (Online)

For additional information:
http://content.karger.com/ProdukteDB/produkte.asp?issn=0250-3751

Book Title: Glaucoma Surgery

Editor(s): Bettin P, Khaw PT (eds)

For additional information:
http://content.karger.com/ProdukteDB/produkte.asp?issn=0250-3751&volume=50


Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: 4/17/2012
Cover Date: 2012

Number of Print Pages: 11
Number of Figures: 2
Number of Tables: 1

ISBN: 978-3-8055-9937-5 (Print)
eISBN: 978-3-8055-9938-2 (Online)


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.